secwatch / observer
8-K filed February 3, 2026, 6:59 PM ET ticker MEVO CIK 0002087361
other material confidence high sentiment neutral materiality 0.50

M Evo Global Acquisition Corp II closes IPO of 30M units at $10, raising $300M

M Evo Global Acquisition Corp II

item 1.01item 3.02item 5.03item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-010970
form_type
8-K
ticker
MEVO
cik
0002087361
company_name
M Evo Global Acquisition Corp II
filed_at
2026-02-03T23:59:59+00:00
discovered_at
2026-05-14T18:02:37.228823+00:00
generated_at
2026-05-16T05:26:35.249075+00:00
sec_items
["1.01", "3.02", "5.03", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-010970
json_url
https://secwatch.observer/filing/0001213900-26-010970.json
markdown_url
https://secwatch.observer/filing/0001213900-26-010970.md
text_url
https://secwatch.observer/filing/0001213900-26-010970.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2087361/000121390026010970/0001213900-26-010970-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2087361/000121390026010970/ea0274988-8k_mevo2.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

60cc16ecb4613c39759ae106541228e14bc410e6

M Evo Global Acquisition Corp II: Adopted Amended and Restated Memorandum and Articles of Association in connection with IPO (effective 2026-01-29).

On January 29, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

1067cee3cf694af450a7fcc53d0059ba6f219386

M Evo Global Acquisition Corp II entered into Underwriting Agreement with Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (effective 2026-01-29).

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

3e2f9112a5b79525b324661fba00a513515f03df

M Evo Global Acquisition Corp II entered into Private Placement Warrant Purchase Agreement with Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (effective 2026-01-29).

A Private Placement Warrant Purchase Agreement, dated January 29, 2026 (the “ CCM Warrant Purchase Agreement ”), by and between the Company and CCM

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

460b79c237b28d10c66f9d3077ca60567f6226dc

M Evo Global Acquisition Corp II entered into Private Placement Warrant Purchase Agreement with Evolution Sponsor Holdings LLC II (effective 2026-01-29).

A Private Placement Warrant Purchase Agreement, dated January 29, 2026 (the “ Sponsor Warrant Purchase Agreement ”), by and between the Company and the Sponsor

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

d08acbf420ff113e1e6bead4c5945e3f98cdd8f8

M Evo Global Acquisition Corp II entered into Registration Rights Agreement with certain security holders (effective 2026-01-29).

● A Registration Rights Agreement, dated January 29, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

f9c2e751420305a9138561f2620ae7b95f9137f4

M Evo Global Acquisition Corp II entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-01-29).

A Warrant Agreement, dated January 29, 2026, by and between the Company and Continental Stock Transfer & Trust Company (“ CST ”), as warrant agent

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 29, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

GIPR

Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit

GENERATION INCOME PROPERTIES, INC. June 1, 2026, 5:27 PM ET other_material Items 1.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

In connection with the Offering, on May 28, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC, as placement agent

Filing page SEC filing

CITR

CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights

CitroTech Inc. June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock

Filing page SEC filing

AIM

AIM ImmunoTech expects ~$4.2M gross from warrant inducement at $0.48/share; new warrants at $0.60

AIM ImmunoTech Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

On May 7, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a warrant exercise inducement offer letter agreement (the “Inducement Letter”) with holders (the “Holders”) of (i) Class A and Class B common stock purchase warrants issued on May 31, 2024

Filing page SEC filing

JPM

JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP

JPMORGAN CHASE & CO May 7, 2026, 7:59 PM ET other_material Items 3.03, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 29, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock

Filing page SEC filing

CURB

Curbline Properties enters up to $400M ATM equity offering; prior program terminated

Curbline Properties Corp. June 2, 2026, 8:07 AM ET other_material Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

On June 2, 2026, Curbline Properties Corp. (the “ Company ”) and Curbline Properties LP (the “ Operating Partnership ”) entered into an ATM Equity Offering Sales Agreement (the “ Equity Sales Agreement ”) with Jefferies LLC, BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, Nomura Securities International, Inc., StoneX Financial Inc. and Wells Fargo Securities, LLC, as sales agents

Filing page SEC filing

BJDX

Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing

Bluejay Diagnostics, Inc. June 2, 2026, 6:30 AM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

On May 27, 2026, Bluejay Diagnostics, Inc. (the “Company”) entered into an agreement and statement of work (together, the “Agreement”) with Argonaut Manufacturing Services c/o Argonaut, Inc. (“Argonaut”) regarding the provision by Argonaut to the Company of certain manufacturing services to support the Company’s SymphonyTM platform.

Filing page SEC filing

GNK

Genco Shipping amends shareholder rights plan, eliminates 'Acting in Concert' definition

GENCO SHIPPING & TRADING LTD June 2, 2026, 6:01 AM ET other_material Items 1.01, 3.03, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

An Underwriting Agreement (the “ Underwriting Agreement ”), dated January 29, 2026, between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (“ CCM ”) as representatives of the several underwriters

Comparable filing

On June 2, 2026, Genco Shipping & Trading Limited (the “ Company ”) entered into the Third Amendment to Shareholders Rights Agreement (the “ Third Amendment ”) to amend the Shareholder Rights Agreement, dated as of October 1, 2025 between the Company and Computershare Inc., as amended to date (the “ Rights Agreement ”).

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-010970
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.